Larimar Therapeutics (LRMR) Short-term Investments (2016 - 2020)
Historic Short-term Investments for Larimar Therapeutics (LRMR) over the last 7 years, with Q3 2020 value amounting to $1.0 million.
- Larimar Therapeutics' Short-term Investments fell 9741.14% to $1.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.0 million, marking a year-over-year decrease of 9741.14%. This contributed to the annual value of $43.0 million for FY2019, which is 3736.82% down from last year.
- As of Q3 2020, Larimar Therapeutics' Short-term Investments stood at $1.0 million, which was down 9741.14% from $1.0 million recorded in Q2 2020.
- Over the past 5 years, Larimar Therapeutics' Short-term Investments peaked at $134.7 million during Q1 2016, and registered a low of $1.0 million during Q3 2020.
- Over the past 5 years, Larimar Therapeutics' median Short-term Investments value was $68.2 million (recorded in 2019), while the average stood at $65.0 million.
- In the last 5 years, Larimar Therapeutics' Short-term Investments skyrocketed by 5746.33% in 2019 and then plummeted by 9814.22% in 2020.
- Quarter analysis of 5 years shows Larimar Therapeutics' Short-term Investments stood at $96.8 million in 2016, then tumbled by 36.73% to $61.3 million in 2017, then rose by 12.17% to $68.7 million in 2018, then plummeted by 37.37% to $43.0 million in 2019, then plummeted by 97.67% to $1.0 million in 2020.
- Its last three reported values are $1.0 million in Q3 2020, $1.0 million for Q2 2020, and $24.9 million during Q1 2020.